MedTrace Logo

Interindividual Variation in Response to Green Coffee

NCT06204445 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-12-11

No results posted yet for this study

Summary

The study is a multifaceted approach to investigate the effects of regular consumption of green coffee rich in polyphenols (hydroxycinnamic acids) on weight, body composition, cardiometabolic and inflammatory biomarkers in a sample population of overweight and obese people aimed at identifying a population of responders to green coffee experimenting the highest benefit from this product, and to contribute to the understanding of the influence of some of the main factors on the response to green coffee and their association with the differences between individuals (high-responders vs. low-responders).

Conditions

  • Overweight and Obesity

Interventions

DIETARY_SUPPLEMENT

Green coffee

Each cup of coffee provides approximately 400 mg of hydroxycinnamic acids.

DIETARY_SUPPLEMENT

Roasted coffee

Each cup of coffee provides approximately 150 mg of hydroxycinnamic acids.

Sponsors & Collaborators

  • Ministry of Science and Innovation, Spain

    collaborator OTHER_GOV

  • Instituto de Ciencia y Tecnología de Alimentos y Nutrición

    lead OTHER_GOV

Principal Investigators

  • Laura Bravo, Prof · Instituto de Ciencia y Tecnología de Alimentos y Nutrición

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-13
Primary Completion
2024-12-13
Completion
2025-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06204445 on ClinicalTrials.gov